Lorvotuzumab (Anti-NCAM1 / CD56)
Product Specifications
CAS Number
339306-30-8
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Lorvotuzumab (Anti-NCAM1 / CD56) is a humanized monoclonal antibody that binds CD56 (NCAM1) . Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine. MW: 145.5 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400630-500 1x 500 µL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470173-500 1x 500 µL
CD45 / LCA (136-4B5), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681731-100 1x 100 µL
Chromogranin A / CHGA (Neuroendocrine Marker) (CHGA/1731R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402759-100 1x 100 µL
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041130-500 1x 500 µL
MUC18 / Mucin 18 / CD146 (MUC18/1130), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details